STLN
Starling Oncology Inc.
STLN | NASDAQ
$6.53
-$0.12 (-1.80%)
At close: Oct 30, 2026, 3:59 PM ET
$6.61
+$0.08 (+1.27%)
Pre-market:
Nov 2, 2026, 9:26 AM ET
Market Data
Market Cap $652.39M
Enterprise Value $715.77M
Beta 0.42
Average Volume 1.5M
Shares Outstanding (Diluted) 103.03M
Shares Change YoY N/A
Institutional Ownership N/A
Exchange NASDAQ
ISIN US68236X1000
Price Performance
Price Change 1M 3.3%
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -6.2%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR 45.7%
Valuation
PE Ratio -21.77
Forward PE N/A
PEG Ratio 0.32
Forward PEG 0.30
PS Ratio 1.11
Forward PS 0.70
PB Ratio -26.19
P/FCF Ratio -198.54
P/Adj. FCF Ratio -77.82
P/OCF Ratio N/A
EV/Sales 1.22
EV/EBIT -24.97
EV/EBITDA -32.75
EV/FCF -217.82
Earnings Yield -4.6%
FCF Yield -0.5%
Adj. FCF Yield -1.3%
Financial Health
Net Debt $38.77M
Total Debt $104.48M
Cash & Short-Term Investments $41.09M
Total Assets $178.23M
Current Ratio 1.36
Quick Ratio 1.15
Debt / Equity Ratio -4.19
Debt / EBITDA -4.78
Debt / FCF -31.79
OCF / Debt 0.00
Interest Coverage -3.42
Altman Z-Score 2.69
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 15.7%
Operating Profit Margin -4.4%
EBITDA Margin -3.7%
Net Profit Margin -6.2%
FCF Margin -0.6%
Adj. FCF Margin -1.4%
SBC / Revenue 0.9%
SBC Impact (per share) -155.1%
Returns
Return on Assets -20.4%
Return on Equity 209.8%
Return on Invested Capital -28.8%
Return on Capital Employed -31.3%
Return on Tangible Assets -22.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 6, 2026
EPS Estimate (next Q) -$0.06
EPS Growth Est (next Q) -57.3%
Revenue Est (next Q) $155.74M
Revenue Growth Est (next Q) 30.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $9.00
Price Target Upside 37.8%
Cash Flow
Operating Cash Flow $328K
Free Cash Flow $-3.29M
Adj. Free Cash Flow $-8.38M
FCF Per Share -$0.03
OCF Per Share $0.00
OCF/S Ratio 0.1%
Income Statement
Revenue $587.24M
Gross Profit $92.17M
Operating Income $-26.09M
EBITDA $-21.86M
Net Income $-36.29M
EPS (Diluted) -$0.30
Revenue / Employee $916.14K
Profit / Employee $-56.62K
Employees 641
Add to Watchlist
Select watchlists to add or remove STLN